$FISV

DiSimone Harry purchased $101K of FISV

DiSimone Harry purchased 2,088 shares of FISERV INC (FISV) at $48.41 ($0.10M total) on 2026-06-16.

Original reporting
SEC EDGAR · DiSimone Harry
Published Jun 16, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:24 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FISV
Bullish
low confidence
Mentioned
$FISV
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FISVBullishLow
01

Why it matters

The newest fact is the director’s open-market purchase details (shares, price, total value, and post-transaction holdings).

02

Market read

Traders may log the insider buy as a small sentiment input, but there is no fundamental update in the filing text provided.

03

What to watch

The article does not state whether the purchase was part of any broader compensation or tax-related activity, and it provides no follow-on guidance or performance context.

Relevance 5/10Novelty 3/10Timing: filed on 2026-06-16, after-hours/close timing for traders to note

Background

The article is an SEC Form 4 insider transaction disclosure for Fiserv, Inc.

Company-level read

Ticker impact

$FISVBullishLow confidence
Context

FISV disclosed an insider Form 4 showing director DiSimone Harry bought 2,088 shares for about $101,080 on 2026-06-16.

Expected impact

Low likelihood of a sustained price move; any effect is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan and no accompanying corporate event, guidance, or operational change.

Market effects

Minimal; this is company-specific insider activity with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

Insider buys can be driven by diversification, liquidity needs, or pre-planned behavior, so the signal may be weak.

Key entities

  • FISERV INC

    Subject of the Form 4 insider transaction disclosure.

  • DiSimone Harry

    Director who purchased 2,088 shares on 2026-06-16.

Related articles

$FISVMedAI 8/10

Fiserv Q2 Earnings Call Highlights

Fiserv (FISV) reported Q2 adjusted operating income near $1.6B, adjusted operating margin of 31.8%, adjusted EPS of $1.84, and free cash flow of $1.1B. It guided 2026 organic revenue growth of -1% to flat and adjusted EPS of $7.20 to $7.40. The company cited FX impacts in Latin America and delays in newly contracted revenue, and discussed divestitures and Project Elevate savings.

Med

Fiserv, Inc. Q2 2026 Earnings Call Summary

Fiserv reported a Q2 2026 earnings call update, revising full-year 2026 organic revenue guidance to minus 1% to flat, citing Argentina macro volatility, slower client implementation timelines, slower execution on growth initiatives, and incremental technology infrastructure investments. Management said recurring revenue is about 85% of adjusted revenue. Fiserv plans >$100M tech spend in H2 2026, divests non-core businesses, and expects double-digit adjusted EPS growth in 2027-2029.

Med

Another tough quarter for Fiserv may lead to product changes

Fiserv reported 2Q revenue down 3% year over year and EPS down 21% to $1.84, missing Wall Street estimates. The company lowered its 2026 outlook, now expecting organic revenue -1% to flat and adjusted EPS $7.20 to $7.40. CEO Takis Georgakopoulos said it is reviewing products and has divested student loan servicing and managed ATM businesses, while analysts cite Clover growth potential.

$FISVHighAI 8/10

FISV Q2 Earnings Call Resets Outlook on Delays, Tech Spend

Fiserv reset its 2026 outlook on its Q2 2026 earnings call, citing slower client implementations, weaker Argentina conditions, and execution gaps. Adjusted EPS was $1.84 vs $1.89 consensus, and adjusted revenue was $4.96B vs $5.05B. 2026 organic revenue growth is now -1% to flat, with adjusted EPS $7.20 to $7.40.

Med

Fiserv Puts Clover at Center of Its Technology Reset

Fiserv said its Q2 results matched forecasts but revised its next six-month outlook. For 2026, it expects organic revenue down 1% or flat and adjusted EPS of $7.20 to $7.40. CFO Paul Todd cited delayed contracted revenue, slower enterprise launches, lower product revenue, and Argentina/planned sales. Q2 revenue was $5.29B, EPS $1.17, and quarterly free cash flow $1.1B.

$SNDKMed

Futures Flat As Tech Slides After Memory Stocks, Korea Tumble

US stock index futures were mixed, with S&P futures up 0.1% and Nasdaq futures down 0.5% as Sandisk (SNDK) fell about 9% and Western Digital (WDC) about 15% after earnings and weaker memory outlooks. Tech and AI names also dropped on results or guidance misses, while Mag 7 were mixed. Asian markets declined after chip-related losses, and investors awaited US payrolls.